Home
About
Overview
Sharing Data
ORCID
Help
History (1)
No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.
No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes. Urol Oncol. 2011 May-Jun; 29(3):319-23.
View in:
PubMed
subject areas
Adenocarcinoma
Aged
DNA, Neoplasm
Follow-Up Studies
Genotype
Humans
Male
Polymerase Chain Reaction
Polymorphism, Single Nucleotide
Prognosis
Prostatectomy
Prostatic Neoplasms
Proto-Oncogene Proteins c-mdm2
Survival Rate
authors with profiles
Jerry J Jaboin